
Alicia Paini
Phd, ERT – Consulting & ResearchAlicia leads research programs on developing and applying physiologically based kinetic (PBK) models and developing strategies for new approach methodologies for chemical risk assessment. She is leading WP4 (kinetic domain) of the EU-funded project ONTOX. She is part, with ESQ-tox team, of two EFSA projects on immunotoxicity and PFAS and ADME; she is the scientific coordinator for an EFSA project where a roadmap for aggregated exposure will be developed. Internationally she is involved in OECD efforts on DNT and biomarkers for AOPs; in the ISES - EU chapter working groups; the HESI-PBPK model working group.
She studied Food Science and Technology at the University of Parma (2005), where she is from. She continued her studies in the Netherlands, where she received an MSc in Food Safety (2007) and a doctorate in Toxicology from Wageningen University (2012). The Ph.D. was performed at the Nestlé Research Center near Lausanne (Switzerland). Alicia was a postdoctoral scholar at the European Commission Joint Research Center (EC-JRC) from 2012 to 2015. In 2015 she continued working at the EC JRC as a scientific project officer, promoting computational modeling in risk assessment and policy making.
Alicia was part of (and leading) the international group that drafted the OECD GD on PBK models published in 2021. She is the author/co-author of more than 70 peer-reviewed articles. She is a European Registered Toxicologist since 2013.
Work with me
- Scientist Systems Pharmacology: PBPK/QSP (m/f/d) Consulting & Research · Saterland / Home Office (100%) · Fully Remote
- Senior/Principal Scientist Systems Pharmacology (m/f/d) Consulting & Research · Saterland / Home Office (100%) · Fully Remote
- Director/Lead Systems Pharmacology: PBPK/QSP (m/f/d) Consulting & Research · Saterland / Home Office (100%) · Fully Remote